Suicidal Ideation: Clinical Trials

10 trials for Suicidal Ideation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 10
Phase 12Completed 2
Phase 32Completed 2

Follow Suicidal Ideation: new trials by email Literature Review of Suicidal Ideation trials Research Report on Suicidal Ideation

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NRX-101 for Bipolar Depression With Subacute Suicidal Ideation
NRX-101, Lurasidone HCl - Bipolar Depression, Suicidal Ideation and Behavior
Phase 2 / Phase 3CompletedNeuroRx, Inc.742022-05-122024-05-08
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Psilocybin - Treatment Resistant Depression, Suicidal Ideation
Phase 2CompletedSheppard Pratt Health System202022-03-282025-12-24
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
SLS-002, Placebo, Standard of care - Depressive Disorder, Major, Suicidal
Phase 2CompletedSeelos Therapeutics, Inc.1642020-12-172023-09-28
NRX101 Glx Biomarker Validation Study
NRX-101, Lurasidone HCl, Placebo - Bipolar Depression, Suicidal Ideation
Phase 2 / Phase 3CompletedNeuroRx, Inc.82018-11-012022-08-09
Electrophysiological Biomarkers of AV-101
Placebo, AV-101 720 mg, AV-101 1440 mg - Healthy
Phase 1 / Phase 2CompletedMarijn Lijffijt, PhD182018-09-012022-02-17
Sequential Therapy for the Treatment of Severe Bipolar Depression.
NRX-101 Oral Capsule, Lurasidone Oral Capsule, Ketamine Intravenous Infusion - Bipolar Depression, Suicidal Ideas
Phase 2CompletedNeuroRx, Inc.222018-01-152021-05-25
Aftercare Focus Study (AFS): A Clinical Trial to Reduce Short-Term Suicide Risk After Hospitalization
Collaborative Assessment and Management of Suicidality, Treatment as Usual - Suicidal Ideation, Suicide, Attempted
Phase 2CompletedUniversity of Washington1502015-08-012021-01-05
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
ketamine - Major Depressive Disorder
Phase 2CompletedUniversity of Alabama at Birmingham2472015-04-202022-08-30
Ketamine for Suicidality in Bipolar Depression
Ketamine, Midazolam - Bipolar Disorder, Major Depressive Episode
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute162013-09-012020-03-11
Social Connections and Healthy Aging (The Senior Connection)
Peer Companionship - Suicidal Ideation, Depression
Phase 2CompletedUniversity of Rochester3682011-09-012016-04-22

Narrower conditions

Bipolar Disorder (4)  ·  Depression (4)  ·  Depressive Disorder, Major (3)  ·  Suicide (3)  ·  Suicide, Attempted (3)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Self-Injurious Behavior (1)

Broader conditions

Behavior (9)  ·  Behavioral Symptoms (9)  ·  Self-Injurious Behavior (9)  ·  Suicide (7)  ·  Mental Disorders (6)  ·  Mood Disorders (6)  ·  Bipolar and Related Disorders (4)  ·  Depressive Disorder (2)

Interventions

Ketamine (3)  ·  Lurasidone Hydrochloride (3)  ·  Cycloserine (1)  ·  Midazolam (1)  ·  Psilocybin (1)  ·  Standard of Care (1)  ·  Therapeutics (1)

Sponsors

NeuroRx, Inc. (3)  ·  Marijn Lijffijt, PhD (1)  ·  New York State Psychiatric Institute (1)  ·  Seelos Therapeutics, Inc. (1)  ·  Sheppard Pratt Health System (1)  ·  University of Alabama at Birmingham (1)  ·  University of Rochester (1)  ·  University of Washington (1)

Countries

United States (9)

Top investigators

Andrew A Nierenberg, MD (1)  ·  Andrew Nierenberg, MD (1)  ·  Daniel C Javitt, MD (1)  ·  Jonathan C Javitt, MD, MPH (1)  ·  Joshua T Kantrowicz, MD (1)  ·  Katherine A Comtois, PhD, MPH (1)  ·  Marijn Lijffijt, PhD (1)  ·  Martin Brecher, MD (1)  ·  Michael F Grunebaum, M.D. (1)  ·  Richard C Shelton, M.D. (1)  ·  Scott Aaronson, MD (1)  ·  Yogesh Dwivedi, Ph.D. (1)

Results publications

PMID 32785636, PMID 33318635, PMID 33825765, PMID 34149476, PMID 35735167, PMID 37573534, PMID 39714786, PMID 42138588

NIH funding

R01MH107183 (1)